Rising crude oil prices lifted the markets to a higher open with the Dow gaining 30 points to 16,630. Nasdaq held steady at 4,860.
On the upside
Intra-Cellular Therapies (Nasdaq: ITCI) reported positive results from a Phase 3 clinical trial of ITI-003 to treat patients with schizophrenia.
OMRON will acquire Adept Technology (Nasdaq: ADEP) for a premium of approximately $200 million.
Shares of Molson Coors Brewing (NYSE: TAP) continued soaring.
On the downside
Newpark Resources (NYSE: NR) announced a new ultra-deepwater contract offshore Uruguay and modified its stock repurchase program but the stock price fell.
Profit taking weighed down shares of Amicus Therapeutics (Nasdaq: FOLD).
Paycom Software (NYSE: PAYC) announced a secondary offering of 4.5 million common shares at the discounted price of $37.95 per share.
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 3 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 added 4 points to 1,982. Bitcoin eased a fraction to $227.